Join Us

We are 224,253 members in 83 forums discussing 163,464 topics.

Help with Abbreviations

Topic: Breastcancer.org Podcasts: Listen to Experts Discuss

Forum: Mod Announcements, Breastcancer.org News, Blog Entries, Podcasts —

Moderator generated forum to present our announcements or requests, organization and website news, blog entries and podcasts. Please do not post here if you are not a Moderator. Thank you!

Posted on: Dec 12, 2013 10:28AM - edited Oct 5, 2014 02:45PM by Moderators

Moderators wrote:

Please go here to read about and listen to all our Podcasts! We will also be posting podcasts below as they air.

Note: Podcasts will be available in transcript form about 24 - 48 hours after the Podcasts have aired.

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Page 8 of 8 (226 results)

Posts 211 - 226 (226 total)

Log in to post a reply

Jan 22, 2021 04:37PM Moderators wrote:

Intermittent Fasting: Can it Help With Weight Loss?

January 22, 2021

Iyengar neil

Dr. Neil Iyengar is a medical oncologist at Memorial Sloan Kettering Cancer Center whose practice focuses on people with breast cancer.

His research is looking at the links between metabolic health and cancer, specifically looking at how diet, exercise, and medicines can prevent cancers tied to obesity, such as breast cancer, and improve outcomes for people with inflammation in fatty tissues.

Listen to the episode to hear Dr. Iyengar explain:

  • what intermittent fasting is and how it was developed
  • why some people think intermittent fasting could be a tool to prevent breast cancer
  • the research done so far
  • the risks of intermittent fasting and what people who want to try it should consider

Running time: 21:40

Listen now or read the transcript.

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Mar 3, 2021 12:25PM Moderators wrote:

Talking to Your Doctor About Going Flat

February 17, 2021

Attai deanna

Dr. Deanna Attai is associate clinical professor of surgery at the David Geffen School of Medicine at UCLA. Dr. Attai was an early adopter of social media for professional and patient education. She serves as the social media editor for the Journal of Oncology Practice and is a member of the Annals of Surgical Oncology editorial board. She is a member of the American Society of Clinical Oncology Social Media Working Group and co-chair of the Collaborative for Outcomes in Social Media in Oncology research group.

Much of her recent research has focused on going flat and how satisfied women are with this decision, as well as whether surgeons support women who want to go flat.

Listen to the podcast to hear Dr. Attai explain:

  • the reasons why a woman may opt to go flat
  • why she decided to study how satisfied women were with their decision to go flat
  • how a woman should talk to her surgeon to ensure she gets a truly flat chest that she is happy with cosmetically after mastectomy, with symmetrical scars and no dog ears

Running time: 29:15

Listen now or read the transcript.
To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Mar 16, 2021 03:42PM Moderators wrote:

Immunotherapy Side Effects

March 3, 2021

Litton jennifer

Dr. Jennifer Litton is a board-certified medical oncologist and professor of breast medical oncology at the University of Texas MD Anderson Cancer Center in Houston, TX, where she is vice president of clinical research. She also is a member of the Breast Immuno-Oncology Task Force of the National Cancer Institute.

Dr. Litton joins us for this episode to talk about the side effects that may be caused by the two immunotherapy medicines approved for breast cancer: Keytruda (chemical name: pembrolizumab) and Tecentriq (chemical name: atezolizumab).

Listen to the podcast to hear Dr. Litton explain:

  • how these two immunotherapy medicines work
  • the side effects that are unique to the immunotherapy medicines
  • how doctors monitor immunotherapy side effects
  • tips how people can monitor themselves for side effects

Running time: 20:44

Listen now or read the transcript.
To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Mar 19, 2021 04:24PM Moderators wrote:

Update on COVID-19 Vaccines

March 12, 2021

Moore halle cleveland clinic

Dr. Halle Moore is director of breast medical oncology and co-director of the Comprehensive Breast Cancer Program at the Cleveland Clinic. Her research focuses on breast cancer treatment and issues related to cancer survivorship.

Since the first COVID-19 vaccines were approved, she has been advising people diagnosed with cancer about what they need to know about being vaccinated. In this episode, she gives us an update on COVID vaccines, as well what people with allergies to polyethylene glycol and polysorbate should consider before being vaccinated.

Listen to the podcast to hear Dr. Moore explain:

  • how the technology of the Johnson & Johnson vaccine differs from the technology of the Pfizer-BioNTech and Moderna vaccines
  • why the vaccines can't be compared head-to-head
  • how she is advising people with polyethylene glycol and polysorbate allergies about the COVID vaccines
  • what people currently being treated for breast cancer need to consider before being vaccinated

Running time: 18:14

Listen now or read the transcript.
To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Mar 30, 2021 03:35PM Moderators wrote:

Scalp Cooling: How It Works to Preserve Hair

March 23, 2021

Isakoff steven

Dr. Steven Isakoff is a medical oncologist who serves as associate director for clinical research at the Massachusetts General Hospital Cancer Center and also as director of the Mass General Scalp Cooling Program and the Triple Negative Breast Cancer Program. He is also an assistant professor of medicine at Harvard Medical School.

Listen to the podcast to hear Dr. Isakoff explain what scalp cooling is and how it works, including:

  • the differences between automated scalp cooling systems and manual cold caps
  • the factors that influence how effective scalp cooling can be at preserving hair during chemotherapy
  • the biological mechanism of how scalp cooling works
  • his tips for anyone who wants to try scalp cooling

Running time: 25:33

Listen now or read the transcript.
To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Apr 3, 2021 11:50AM Moderators wrote:

American Rescue Plan: Benefits for the Breast Cancer Community

March 29, 2021

Morales joanna preferred

Joanna Fawzy Morales is a cancer rights attorney, author, speaker, and CEO of Triage Cancer, a national nonprofit organization providing free education on the legal and practical issues that may affect people diagnosed with cancer and their caregivers. Joanna has spent more than 27 years working on behalf of people with cancer, including 5 as an adjunct professor of law at Loyola Law School, teaching a seminar in cancer rights law, and 8 years at the John Wayne Cancer Institute's Psychosocial Care Program. Currently, she's also an adjunct law professor at Wayne State University.

Listen to the episode to hear her explain the American Rescue Plan and the benefits it may offer to people diagnosed with breast cancer, including:

  • additional economic impact payments for individuals who make up to $75,000 or couples who make up to $150,000
  • the increase in health insurance marketplace subsidies
  • when the benefits begin and how long they will last

Running time: 27:27

Listen now or read the transcript.
To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Apr 20, 2021 03:19PM Moderators wrote:

J&J COVID Vaccine and Blood Clots: What This Means for People With Breast Cancer

April 13, 2021

Brian wojciechowski md final 6340

Brian Wojciechowski, M.D., practices medical oncology in Delaware County, Pennsylvania, at Riddle, Taylor, and Crozer hospitals and also serves as Breastcancer.org's medical adviser.

The U.S. Food and Drug Administration and the Centers for Disease Control have recommended that use of the Johnson & Johnson-Janssen COVID-19 vaccine be paused because six cases of what's called cerebral venous sinus thrombosis with thrombocytopenia have been diagnosed after people received the vaccine. Basically, a blot clot was found in the veins that drain blood from the brain, and the people also had very low levels of platelets, a type of cell that helps the blood to clot.

Listen to the episode to hear Dr. Wojciechowski explain:

  • what these rare clots are and how they happen
  • what people who've received the J&J vaccine should know
  • how he's advising his patients with breast cancer

Running time: 22:08

Listen now or read the transcript.
To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

May 5, 2021 02:20PM Moderators wrote:

Lymphedema 101

April 28, 2021

Beck marcia2

Marcia Beck is a clinical nurse specialist at the University of Kansas Health System. Marcia is certified in adult health and breast health and also certified as a lymphedema therapist by the Lymphology Association of North America.

Listen to the episode to hear Marcia explain all aspects of lymphedema, including:

  • what lymphedema is and where it can develop
  • risk factors for lymphedema
  • how lymphedema is treated
  • steps people can take to reduce their risk of lymphedema or lymphedema flare-ups

Running time: 28:48

Listen now or read the transcript.
To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Jun 2, 2021 02:28PM Moderators wrote:

Breast Self-Exam

May 28, 2021

Brian wojciechowski md final 6340

Brian Wojciechowski, M.D., practices medical oncology in Delaware County, Pennsylvania at Riddle, Taylor, and Crozer hospitals and also serves as Breastcancer.org's medical adviser. He is a sought-after speaker on the topics of medical ethics and the biology of cancer.

Medical and oncology organizations disagree on the value of breast self-exam. The American Cancer Society, for example, doesn't recommend breast self-exam, while Breastcancer.org believes they are part of a comprehensive screening plan. Dr. Wojciechowski joined us to talk about the role of breast self-exam in screening and why it's controversial.

Listen to the podcast to hear Dr. Wojciechowski explain:

  • why organizations stopped recommending breast self-exam
  • the benefits and drawbacks of breast self-exam
  • how he talks to his patients about breast self-exam

Running time: 12:02

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Jun 11, 2021 03:51PM Moderators wrote:

Breast Cancer Recurrence Risk

June 9, 2021

Brian wojciechowski md final 6340

Brian Wojciechowski, M.D., practices medical oncology in Delaware County, Pennsylvania at Riddle, Taylor, and Crozer hospitals and also serves as Breastcancer.org's medical adviser. A native of South Philadelphia, he trained at Temple University School of Medicine and Lankenau Medical Center. Dr. Wojciechowski is a sought-after speaker on the topics of medical ethics and the biology of cancer.

One of the goals of treatment for DCIS and early-stage breast cancer — which is stage I, II, or stage III cancer — is to stop the cancer from coming back, called recurrence by doctors. Dr. Wojciechowski joined us to talk about recurrence risk and how it's estimated.

Listen to the episode to hear Dr. Wojciechowski discuss:

  • the factors used to determine each breast cancer's risk of recurrence
  • the steps a person can take to help keep the risk of recurrence as low as it can be
  • how tests called tumor genomic assays can help estimate the risk of recurrence

Running time: 16:39

Listen now or read the transcript.
To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Jun 26, 2021 01:57PM Moderators wrote:

Breast Cancer, a CEO, and a New Nonhormonal Birth Control

June 25, 2021

Saundra pelletier head shot

Saundra Pelletier is the CEO and founder of Evofem Biosciences. Saundra was diagnosed with stage III breast cancer while her company was conducting phase III clinical trials on Phexxi, a nonhormonal contraceptive gel for women. She describes herself as a mother, daughter, CEO, and trailblazer. She has more than two decades of experience of executive leadership at companies and nonprofits focusing on women's health.

Listen to the episode to hear Saundra discuss:

  • how she led her company without taking a leave of absence while being treated for breast cancer
  • how breast cancer changed her
  • how Phexxi, a nonhormonal birth control gel, was developed, how it works, and why it's safe for women who've been diagnosed with breast cancer
  • her advice for women who've just been diagnosed with breast cancer

Running time: 47:05

Listen now or read the transcript.

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Jul 8, 2021 02:29PM Moderators wrote:

Breast Cancer Research at the 2021 ASCO Annual Meeting

June 28, 2021

Litton jennifer

Dr. Jennifer Litton is a board-certified medical oncologist and professor of breast medical oncology at the University of Texas MD Anderson Cancer Center in Houston, where she is also vice president of clinical research.

The 2021 American Society of Clinical Oncology annual meeting was held virtually June 4-8, and there were a number of studies on breast cancer presented. Dr. Litton joined us to talk about some of the most notable research.

Listen to the episode to hear her explain:

  • results from the OlympiA trial, showing that Lynparza (chemical name: oliparib) offered benefits for early-stage breast cancer in people with a BRCA1 or BRCA2 mutation
  • results from the NEOTALA trial showing that Talzenna (chemical name: talazoparib) offered benefits for early-stage breast cancer in people with a BRCA1 or BRCA2 mutation when given before surgery
  • updated results showing continued better overall survival when advanced-stage, hormone-receptor-positive, HER2-negative breast cancer is treated with the CDK4/6 inhibitors Ibrance (chemical name: palbociclib) or Kisqali (chemical name: ribociclib)

Running time: 23:19

Listen now or read the transcript.
To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Jul 22, 2021 02:22PM Moderators wrote:

Reconstruction Options After Lumpectomy

July 16, 2021

Gary monique

Dr. Monique Gary is a board-certified, fellowship-trained breast surgical oncologist and medical director of the Grand View Health-Penn Cancer Network Cancer Program in Sellersville, Penn., where she also serves as director of the Breast Program. As a physician, advocate, and expert on health and healthcare disparities, she is passionate about developing integrative, holistic, and innovative approaches to cancer treatment, prevention, and general wellness.

Dr. Gary joined us to talk about oncoplastic lumpectomy surgery, which is lumpectomy to remove the breast cancer followed by immediate breast reconstruction. In many cases, lumpectomy and reconstruction are done during the same surgery. The goal is to have the best possible cosmetic outcomes, without the need for any additional surgery to correct any dents or asymmetry.

Listen to the episode to hear Dr. Gary explain:

  • how and why oncoplastic lumpectomy was developed
  • who is and isn't a good candidate for oncoplastic lumpectomy
  • the benefits and drawbacks of oncoplastic lumpectomy
  • things to consider when deciding between lumpectomy and mastectomy

Running time: 25:05

Listen now or read the transcript.
To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Aug 20, 2021 03:36PM Moderators wrote:

Tattoo Ink Showing Up on Mammograms

August 20, 2021

Summerton susan

Dr. Susan Summerton is associate professor of clinical radiology at the University of Pennsylvania. Dr. Summerton joined us to talk about an issue that many people are unaware of: Ink from tattoos on the upper body migrating to the lymph nodes and showing up as white specs on a mammogram. In some cases, this can lead to more tests to rule out breast cancer.

Listen to the episode to hear Dr. Summerton explain:

  • how tattoo ink ends up in the underarm lymph nodes
  • how often this happens
  • how often tattoo ink leads to more testing
  • what women with tattoos who are getting regular mammograms should know

Running time: 15:26

Listen now or read the transcript.
To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Sep 22, 2021 01:24PM Moderators wrote:

The Importance of Diversity in Breast Cancer Clinical Trials

September 15, 2021

Fayanju lola

Dr. Lola Fayanju is the Helen O. Dickens Presidential Associate Professor at the Perelman School of Medicine at the University of Pennsylvania, where she is also chief of breast surgery at Penn Medicine, as well as surgical director of the Rena Rowan Breast Center. Her research focuses on health disparities, aggressive breast cancer variants, and improving value in oncology.

Studies show that overall participation in cancer clinical trials is low, and participation by people of color is even lower. This is thought to be part of the reason that minority women — especially Black women — have worse breast cancer outcomes than white women.

One strategy to help reduce disparities in breast cancer outcomes is to make clinical trials more diverse.

Listen to the podcast to hear Dr. Fayanju explain:

  • why diversity in clinical trials is important
  • some of the barriers that keep people of color from enrolling in clinical trials and how they can be overcome
  • how she talks to all her patients about clinical trials

Running time: 31:11

Listen now or read the transcript.
To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply

Sep 29, 2021 12:59PM Moderators wrote:

Keytruda Added to Chemotherapy Improves Overall Survival for Metastatic PD-L1-Positive, Triple-Negative Breast Cancer

September 24, 2021

Rugo hope

Dr. Hope Rugo is professor of medicine in the division of hematology and oncology at the University of California San Francisco Helen Diller Family Comprehensive Cancer Center, where she is also the director of breast oncology and clinical trials education. Dr. Rugo is also a member of the Breastcancer.org Professional Advisory Board. She is a principal investigator of a number of clinical trials looking at combining new targeted and immunotherapy medicines with standard treatments for both early-stage and advanced-stage breast cancer and has published hundreds of peer-reviewed papers.

At the European Society for Medical Oncology Congress 2021, Dr. Rugo presented final results from the KEYNOTE-355 trial, which was looking to see if Keytruda (chemical name: pembrolizumab) and chemotherapy were better than chemotherapy alone as a first treatment for metastatic PD-L1-positive, triple-negative breast cancer. Earlier results found that adding Keytruda to chemotherapy improved progression-free survival — how long people lived before the cancer grew — for this type of breast cancer. These new results show that adding Keytruda improves overall survival — how long people live whether the breast cancer grows or not.

Listen to the podcast to hear Dr. Rugo explain:

  • what the KEYNOTE-355 aimed to do
  • whether Keytruda offers benefits for PD-L1-negative disease
  • why it's important for a medicine to improve overall survival as well as progression-free survival
  • the differences in PD-L1 tests and what they mean for the effectiveness of breast cancer checkpoint inhibitor medicines

Running time: 25:03

Listen now or read the transcript.
To send a Private Message to the Mods: community.breastcancer.org/mem...

Page 8 of 8 (226 results)